>
Powerful Pro-life Ad Set to Air During Super Bowl 'Adoption is an Option' (Video)
Even in Winter, the Sun Still Shines in These Citrus Recipes
Dates: The Ancient Fertility Remedy Modern Medicine Ignores Amid Record Low Birth Rates
Amazon's $200 Billion Spending Shock Reveals Big Tech's Centralization Crisis
SpaceX Authorized to Increase High Speed Internet Download Speeds 5X Through 2026
Space AI is the Key to the Technological Singularity
Velocitor X-1 eVTOL could be beating the traffic in just a year
Starlink smasher? China claims world's best high-powered microwave weapon
Wood scraps turn 'useless' desert sand into concrete
Let's Do a Detailed Review of Zorin -- Is This Good for Ex-Windows Users?
The World's First Sodium-Ion Battery EV Is A Winter Range Monster
China's CATL 5C Battery Breakthrough will Make Most Combustion Engine Vehicles OBSOLETE
Study Shows Vaporizing E-Waste Makes it Easy to Recover Precious Metals at 13-Times Lower Costs

Known as the ACES trial, (Advancing CBD Education and Science), participants experienced a 71% improvement in their well-being on average, while 63% experienced an improvement in anxiety and sleep quality, and 47% experienced improvements in pain levels. 61% of participants reported an effect within one to four hours of taking their product.
The group behind the trial is Radicle Science, a health-tech startup looking to revolutionize the way in which natural consumer products are studied and evaluated for efficacy.
"Radicle Science has delivered much-needed clarity to a confusing marketplace where consumers are baffled as to which products and dosages might best serve their needs," says Ethan Russo, MD, one of the study's collaborator working with Radicle. "Radicle is charting a compelling and innovative course towards offering personalized predictive data on the health effects of cannabidiol products consumed by millions of Americans every day".
And indeed it is millions. A 2019 Gallup poll found that an estimated 14%, or at least 1 in 7 Americans that answered Gallup polls, report to use CBD; mostly for pain, even though a Consumer Brand Association study in July of 2021 found that consumer knowledge of CBD is around 3.3 out of 10.
"Despite the massive and growing market size, there is still scant data on the effectiveness of over-the-counter cannabinoid products," says Jeff Chen, MD and CEO of Radicle Science.